Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | ARG2 | P78540 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8632405 | 1.00 | CYP1A2 (0.54) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL2160966 | 1.00 | CYP1A2 (0.54) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL13384365 | 1.00 | CYP1A2 (0.54) | CYP1A2GABRR1LTA4HBLMACE2 | |
| Hydrochloric Acid SCHEMBL28546455 | 0.98 | CYP1A2 (0.52) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL5407252 | 0.88 | GABRR1 (0.54) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL5407249 | 0.88 | GABRR1 (0.54) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL7253734 | 0.87 | CYP1A2 (0.50) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL7253732 | 0.87 | CYP1A2 (0.50) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL21595291 | 0.85 | LTA4H (0.52) | CYP1A2GABRR1LTA4HBLMACE2 | |
| SCHEMBL21595289 | 0.85 | LTA4H (0.52) | CYP1A2GABRR1LTA4HBLMACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382273-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | INST NAT SANTE RECH MED (FR) | 2025-12-18 | — | — | US | claimed |
| CN-117720452-A | Preparation method of 3-aza-tricyclo [4.2.1.0 (2.5) ] nonane-7-ene-4-one | 成都科圣原医药科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| WO-2024011345-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2024-01-18 | — | — | WO | claimed |
| CN-113797969-B | Preparation method of single-molecule nano micelle suitable for acid-base tandem catalysis | 浙江理工大学绍兴柯桥研究院有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116601185-A | Olefin composition comprising hydrocarbon resin | 马特里亚公司 | 2023-08-15 | — | — | CN | claimed |
| CN-116568263-A | Hair care composition comprising malodor reduction materials | 宝洁公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116500858-A | Coating of combined photoresist and Si-based hard mask | 上海艾深斯科技有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116217400-A | Cypress aroma compound and preparation method thereof | 波顿香料股份有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-112778156-B | Bishydrazide structure compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2023-03-14 | — | — | CN | claimed |
| CN-109313388-B | Negative photosensitive composition | 住友电木株式会社 | 2022-06-21 | — | — | CN | claimed |
| CN-114195986-A | Method for preparing polyolefin by metal-catalyzed ring-opening metathesis polymerization | 南京先进生物材料与过程装备研究院有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-113797969-A | Preparation method of monomolecular nano micelle suitable for acid-base tandem catalysis | 浙江理工大学绍兴柯桥研究院有限公司 | 2021-12-17 | — | — | CN | claimed |
| CN-113582980-A | Compound based on heterocyclic ring and glutarimide framework and application thereof | 上海科技大学 | 2021-11-02 | — | — | CN | claimed |
| CN-113423702-A | N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use in the treatment of disease | 诺华股份有限公司 | 2021-09-21 | — | — | CN | claimed |
| CN-112778156-A | Bishydrazide structure compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2021-05-11 | — | — | CN | claimed |
| CN-112739803-A | Fragrance composition containing norbornene derivative | 普罗米鲁斯有限责任公司 | 2021-04-30 | — | — | CN | claimed |
| CN-105899651-B | Benefit agent containing delivery particles based on styrene maleic anhydride copolymers | 宝洁公司 | 2020-02-07 | — | — | CN | claimed |
| EP-1061894-A1 | FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS | Colgate-Palmolive Company (US) | 2000-12-27 | — | — | EP | claimed |
| WO-1999044575-A1 | FRAGRANCE ENHANCING COMPOSITIONS FOR COSMETIC PRODUCTS | COLGATE-PALMOLIVE COMPANY (US) | 1999-09-10 | — | — | WO | claimed |
| EP-0071571-B1 | PHOTOPOLYMERISATION PROCESS | CIBA-GEIGY AG (CH) | 1985-09-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382273-A1 | BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS | BBOX1, NDUFB6, NDUFB5 | CYP1A2 57/4885GABRR1 3186/4885LTA4H 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.